MRI evaluation of neoadjuvant low-dose fractionated radiotherapy with concurrent chemotherapy in patients with locally advanced breast cancer

British Journal of Radiology

Volumn 85, Issue 1019, 2012, Pages

  Bufi, E ^a   Belli, P ^a   Costantini, M ^a   Rinaldi, P ^a   Di Matteo, M ^a   Bonatesta, A ^a   De Santis, M C ^a   Nardone, L ^a   Terribile, D ^b   Mule A ^a   Bonomo, L ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; DOXORUBICIN;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GROWTH; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MASTECTOMY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION DOSE FRACTIONATION; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CLINICAL PROTOCOLS; COMBINED MODALITY THERAPY; DIFFUSION MAGNETIC RESONANCE IMAGING; DOXORUBICIN; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOADJUVANT THERAPY; TAXOIDS;

EID: 84868006049     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/31819475     Document Type: Article

References (25)

1. Chen J, Feig B, Agrawal G, Yu H, Carpenter PM, Mehta RS, et al. MRI evaluation of a pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy. Cancer 2008;112:17-26.
2. Johansen R, Jensen L, Rydland J, Goa PE, Kvistad KA, Bathen TF, et al. Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE-MRI. J Magn Reson Imaging 2009;29:1300-7.
3. Zanelli GD, Quaia M, Robiuex I, Bujor L, Santarosa M, Favaro D, et al. Paclitaxel as a radiosensitiser: a proposed schedule of administration based on in vitro data and pharmacokinetic calculations. Eur J Cancer 1997;33:486-92. (Pubitemid 27168078)
4. Mason KA, Hunter NR, Milas M, Abbruzzese JL, Milas L. Docetaxel enhances tumor radioresponse in vivo. Clin Cancer Res 1997;3:2431-8. (Pubitemid 28133165)
5. Dowell JE, Sinard R, Yardley DA, Aviles V, Machtay M, Weber RS, et al. Seven-week continuous-infusion paclitaxel concurrent with radiation therapy for locally advanced non-small cell lung and head and neck cancers. Semin Radiat Oncol 1999;9:97-101. (Pubitemid 29190418)
6. Nardone L, Valentini V, Marino L, De Santis MC, Terribile D, Franceschini G, et al. A feasibility study of neo-adjuvant low-dose fractionated radiotherapy with two different concurrent anthracycline-docetaxel schedules in stage IIA/B-IIIA breast cancer. Tumori 2012;98:79-85.
7. Formenti SC, Volm M, Skinner KA, Spicer D, Cohen D, Perez E, et al. Pre-operative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a phase I/II trial. J Clin Oncol 2003;21:864-70. (Pubitemid 46606446)
8. Chakravarthy AB, Kelley MC, McLaren B, Truica CI, Billheimer D, Mayer IA, et al. Neoadjuvant concurrent paclitaxel and radiation in stage II/III breast cancer. Clin Cancer Res 2006;12:1570-6.
9. Chendil D, Oakes R, Alcock RA, Patel N, Mayhew C, Mohiuddin M, et al. Low dose fractionated radiation enhances the radiosensitization effect of paclitaxel in colorectal tumor cells with mutant p53. Cancer 2000;89:1893-900.
10. Marples B, Lambin P, Skov KA, Joiner MC. Low dose hyper-radiosensitivity and increased radioresistance in mammalian cells. Int J Radiat Biol 1997;71:721-35. (Pubitemid 27306027)
11. Loo CE, Teertstra H, Rodenhuis S, van de Vijver MJ, Hanneman J, Muller SH, et al. Dynamic contrast enhanced MRI for prediction of breast cancer response to neoadjuvant chemotherapy: initial results. AJR Am J Roentgenol 2008;191:1331-8.
12. Yankeelov TE, Lepagea M, Chakravarthyf A, Boorme EE, Niermann KJ, Kelley MC, et al. Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging 2007;25:1-13. (Pubitemid 46048940)
13. Londero V, Bazzocchi M, Del Frate C, Puglisi F, Di Loreto C, Francescutti G, et al. Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol 2004;14:1371-9. (Pubitemid 39162217)
14. Belli P, Costantini M, Ierardi C, Bufi E, Amato D, Mulé A, et al. Diffusion-weighted imaging in evaluating the response to neoadjuvant breast cancer treatment. Breast J 2011;17:610-19.
15. Dershaw DD, Shank B, Reisinger S. Mammographic findings after breast cancer treatment with local excision and definitive irradiation. Radiology 1987;164:455-61. (Pubitemid 17097966)
16. Schnitt SJ, Connolly JL, Harris JR, Cohen RB. Radiationinduced changes in the breast. Hum Pathol 1984;15:545-50.
17. Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994;73:2680-6. (Pubitemid 24166250)
18. Belli P, Costantini M, Bufi E, Magistrelli A, La Torre G, Bonomo L. Diffusion-weighted imaging in breast lesion evaluation. Radiol Med 2010;115:51-69.
19. Woodhams R, Matsunaga K, Kan S, Hata H, Ozaki M, Iwabuchi K, et al. ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci 2005;4:35-42.
20. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumors: Revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228-47.
21. Kim HJ, Im YH, Han BK, Choi N, Lee J, Kim JH, et al. Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in locally advanced breast cancer: relation to response patterns on MRI. Acta Oncol 2007;46:996-1003. (Pubitemid 47537188)
22. Heywang-Koebrunner SH. Breasts. In: Bradley WG, Stark DD, eds. Magnetic resonance imaging. St. Louis, MO: Mosby; 1999. pp. 1401-28.
23. Enns L, Bogen KT, Wizniak J, Murtha AD, Weinfeld M. Low-dose radiation hyper-sensitivity is associated with p53-dependent apoptosis. Mol Cancer Res 2004;2:557-66. (Pubitemid 39403384)
24. Krueger SA, Joiner MC, Weinfeld M, Piasentin E, Marples B. Role of apoptosis in low-dose hyper-radiosensitivity. Radiat Res 2007;167:260-67. (Pubitemid 351292537)
25. Morse DL, Galons JP, Payne CM, Jennings DL, Day S, Xia G, et al. MRI-measured water mobility increases in response to chemotherapy via multiple cell-death mechanisms. NMR Biomed 2007;20:602-61.